Skip to content

Commit

Permalink
Merge pull request #1276 from bcgov/EDRD-Phase1_defectsFixing
Browse files Browse the repository at this point in the history
Edrd phase1 defects fixing
  • Loading branch information
deepakmulamalla authored Mar 13, 2024
2 parents 9f75bca + 6d447c9 commit c5bb088
Show file tree
Hide file tree
Showing 67 changed files with 6,326 additions and 632 deletions.
Original file line number Diff line number Diff line change
Expand Up @@ -74,6 +74,19 @@
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q22_R1</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q23</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q23_R1</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q2_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q3_R6</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q4_R5</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q5_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q7_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q6_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q8_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q9_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q10_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q11_R5</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q12_R6</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q13_R4</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Gaucher_Submission_AssessmentOfSeverity_Q4_R6</assessmentQuestionDeveloperNames>
<developerName>Gaucher_Submission_AssessmentOfSeverity_QS</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_QS</name>
</AssessmentQuestionSet>
Original file line number Diff line number Diff line change
Expand Up @@ -16,6 +16,25 @@
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q6_R2</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q7</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q8</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R7</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R8</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R9</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R10</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R11</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R12</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R13</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R14</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R15</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R16</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R17</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R18</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R19</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R20</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R21</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R22</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R23</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R24</assessmentQuestionDeveloperNames>
<assessmentQuestionDeveloperNames>Risdiplam_Renewal_Initiation_Criteria_Q3_R25</assessmentQuestionDeveloperNames>
<developerName>Risdiplam_Renewal_Initiation_Criteria_QS</developerName>
<name>Risdiplam_Renewal_Initiation_Criteria_QS</name>
</AssessmentQuestionSet>
Original file line number Diff line number Diff line change
Expand Up @@ -4,11 +4,11 @@
<isActive>true</isActive>
<name>Atypical_Hemolytic_Uremic_Syndrome_Initial_First_Presentation_of_Recurrent_Q15</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>a) Unexplained thrombocytopenia (platelet &lt;150 x 109/L or a significant reduction from baseline) AND the presence of hemolysis (schistocytes AND either increased LDH or low haptoglobin)</questionText>
<questionText>a) Unexplained thrombocytopenia (platelets &lt;150 x 10^9/L or a significant reduction from baseline) AND the presence of hemolysis (schistocytes AND either increased LDH or low haptoglobin)</questionText>
<responseValues>Present
Absent</responseValues>
<status>Active</status>
<versionNumber>2</versionNumber>
<versionNumber>3</versionNumber>
</assessmentQuestionVersion>
<dataType>Radio</dataType>
<developerName>AHUS_Initial_First_Presentation_of_Recurrent_Q15</developerName>
Expand Down
Original file line number Diff line number Diff line change
Expand Up @@ -4,9 +4,9 @@
<isActive>true</isActive>
<name>AHUS_Initial_First_Presentation_of_Recurrent_Q16</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>3. Demonstrate an unacceptable high risk of relapse: either (a) or (b)</questionText>
<questionText>3.Demonstrate the CURRENT presence of TMA in the ALLOGRAFT: either (a) or (b)</questionText>
<status>Active</status>
<versionNumber>2</versionNumber>
<versionNumber>3</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>AHUS_Initial_First_Presentation_of_Recurrent_Q16</developerName>
Expand Down
Original file line number Diff line number Diff line change
Expand Up @@ -4,8 +4,7 @@
<isActive>true</isActive>
<name>Atypical_Hemolytic_Uremic_Syndrome_Initial_First_Presentation_of_Recurrent_Q17</name>
<optionSourceResponseValue>true</optionSourceResponseValue>
<questionText>a) Unexplained thrombocytopenia (platelet &lt;150 x 109/L or a significant reduction from baseline) AND the presence of hemolysis (schistocytes AND either
increased LDH or low haptoglobin)</questionText>
<questionText>a) Unexplained thrombocytopenia (platelets &lt;150 x 10^9/L or a significant reduction from baseline) AND the presence of hemolysis (schistocytes AND either increased LDH or low haptoglobin)</questionText>
<responseValues>Present
Absent</responseValues>
<status>Active</status>
Expand Down
Original file line number Diff line number Diff line change
Expand Up @@ -4,7 +4,7 @@
<isActive>true</isActive>
<name>Atypical_Hemolytic_Uremic_Syndrome_Initial_First_Presentation_of_Recurrent_Q20</name>
<optionSourceResponseValue>true</optionSourceResponseValue>
<questionText>a) Provide a clinical synopsis ruling out the other causes of current TMA listed in Section A part 1, include results for transplant-specific causes of TMA including CMV, Parvovirus B19, etc...</questionText>
<questionText>a) Provide a clinical synopsis ruling out the other causes of current TMA listed in questions 1a-1k, include results for transplant-specific causes of TMA including CMV, Parvovirus B19, etc</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
Expand Down
Original file line number Diff line number Diff line change
Expand Up @@ -4,13 +4,13 @@
<isActive>true</isActive>
<name>Cystic_Fibrosis_Intial_Assessment_Of_severity_Q1_R2</name>
<optionSourceResponseValue>true</optionSourceResponseValue>
<questionText>Expected Outcomes: Sweat chloride levels decrease below 60 mmol/litre or by at least 30% from baseline;
<questionText>Expected Outcomes: Sweat chloride levels decrease below 60 mmol/litre or by at least 30 percent from baseline;
OR
If baseline levels lower than 60 mmol/litre, decrease by at least 30% or sustained absolute improvement in FEV1 ≥ 5%.
If baseline levels lower than 60 mmol/litre, decrease by at least 30 percent or sustained absolute improvement in FEV1 ≥ 5 percent.

Discontinuation Criteria: Failure to achieve expected outcomes</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
<versionNumber>2</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Cystic_Fibrosis_Intial_Assessment_Of_severity_Q1_R2</developerName>
Expand Down
Original file line number Diff line number Diff line change
Expand Up @@ -4,7 +4,7 @@
<isActive>true</isActive>
<name>EculizumabPNH_Initial_AssessmentOfSeverityAndMeasures_Q3</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>PNH granulocyte and/or monocyte clone (provide dates and values)</questionText>
<questionText>PNH granulocyte and/or monocyte clone size (provide dates and values)</questionText>
<status>Active</status>
<versionNumber>2</versionNumber>
</assessmentQuestionVersion>
Expand Down
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q10_R4</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Liver synthetic dysfunction</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q10_R4</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q10_R4</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
Expand Up @@ -5,12 +5,12 @@
<name>Gaucher_Submission_AssessmentOfSeverity_Q11_R3</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Expected outcomes:
Reduction of spleen volume by 50%
Reduction of spleen volume by 50 percent

Discontinuation Criteria (readings consistent over 12 month period):
Spleen volume reduction less than 50%</questionText>
Discontinuation Criteria (readings consistent over 12 month period):
Spleen volume reduction less than 50 percent</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
<versionNumber>2</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q11_R3</developerName>
Expand Down
Original file line number Diff line number Diff line change
Expand Up @@ -5,11 +5,11 @@
<name>Gaucher_Submission_AssessmentOfSeverity_Q11_R4</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Expected outcomes:
Reduction in liver volume by 30%
Discontinuation Criteria (readings consistent over 12 month period):
Liver volume reduction less than 30%</questionText>
Reduction in liver volume by 30 percent
Discontinuation Criteria (readings consistent over 12 month period):
Liver volume reduction less than 30 percent</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
<versionNumber>2</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q11_R4</developerName>
Expand Down
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q11_R5</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Symptomatic hepatosplenomegaly</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q11_R5</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q11_R5</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q12_R6</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Progressive pulmonary</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q12_R6</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q12_R6</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q13_R4</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Growth failure</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q13_R4</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q13_R4</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q2_R4</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Hemoglobin</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q2_R4</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q2_R4</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q3_R6</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Platelet count</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q3_R6</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q3_R6</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
Expand Up @@ -11,11 +11,10 @@ Discontinuation Criteria
(readings consistent over 12 month period) :
Reduction of spleen volume that is less than 50%</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
<versionNumber>3</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q4_R3</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q4_R3</name>
<questionCategory>Demographic</questionCategory>
<relatedQuestion>Gaucher_Submission_AssessmentOfSeverity_Q4</relatedQuestion>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q4_R5</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Splenic infarction</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q4_R5</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q4_R5</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,19 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q4_R6</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Expected outcomes :
Reduction of spleen volume by 50 percent

Discontinuation Criteria (readings consistent over 12 month period) :
Reduction of spleen volume that is less than 50 percent</questionText>
<status>Active</status>
<versionNumber>4</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q4_R6</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q4_R6</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q5_R4</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Bone crises</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q5_R4</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q5_R4</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Original file line number Diff line number Diff line change
@@ -0,0 +1,15 @@
<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
<assessmentQuestionVersion>
<isActive>true</isActive>
<name>Gaucher_Submission_AssessmentOfSeverity_Q6_R4</name>
<optionSourceResponseValue>false</optionSourceResponseValue>
<questionText>Radiographic or MRI</questionText>
<status>Active</status>
<versionNumber>1</versionNumber>
</assessmentQuestionVersion>
<dataType>TextBlock</dataType>
<developerName>Gaucher_Submission_AssessmentOfSeverity_Q6_R4</developerName>
<name>Gaucher_Submission_AssessmentOfSeverity_Q6_R4</name>
<questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
Loading

0 comments on commit c5bb088

Please sign in to comment.